Skip to content
MedsAcross

Medicine

Meropenem 500 mg/20 mL powder for injection

Meropenem · Intravenous
Available on requestPrescription onlyUS FDAGeneric name

Meropenem 500 mg/20 mL powder for injection is a generic prescription medicine for intravenous use, made by 3 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

The dry powder should be stored at controlled room temperature 20° to 25°C…

Key facts

Active ingredient (INN)
Meropenem
Brand
Sold under the generic name
Strength
500 mg/20 mL
Dosage form
Powder for injection
Route
Intravenous
Packs
10 vials
Manufacturers
Amneal PharmaceuticalsSagent Pharmaceuticals3 labelers on the register
Origin register
US FDA, United States
Storage
The dry powder should be stored at controlled room temperature 20° to 25°C (68° to 77°F). 500 mg Injection Vial (NDC 70121-1454-1) [Cartons of 10 - NDC 70121-1454-7] 1 gram Injection Vial (NDC 70121-1453-1) [Cartons of 10 - NDC 70121-1453-7]
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
J01DH02 Meropenem
HS code (indicative)
3004.20Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
9 May 2016
Identifiers
RxCUI 1722934, 1722939DailyMed set ID a456013b-b20e-4b29-b2f9-06f18f1ea6bd, ca5f501c-6520-4d09-aae2-4f5db74d468f, e8848f4a-bca9-4978-b0a1-38483fd4d639NDC 70121-1454, 68001-323, 25021-160Application ANDA205883, ANDA216424

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

Packs from every labeler of this generic presentation.

PackCodeLabelerMarketed since
10 vial, glass in 1 carton / 20 mL in 1 vial, glass70121-1454-7Amneal Pharmaceuticals9 May 2016
10 vial in 1 carton / 20 mL in 1 vial25021-160-20Sagent Pharmaceuticals1 November 2025

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 21 June 1996Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Other strengths and forms of Meropenem

Clinical summary

Meropenem is a penem antibacterial indicated for the treatment of complicated skin and skin structure infections (adult patients and pediatric patients 3 months of age and older requiring the full adult dose only), among other approved uses. MedsAcross supplies Meropenem for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Meropenem

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Meropenem 500 mg/20 mL powder for injection for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.